PCN117 Immune-related adverse events (irAEs) in NSCLC patients treated with programmed cell death 1 (PD-1) inhibitors: An analysis using the data from FDA adverse event reporting system (FAERS)
Abstract
Authors
D. Mazumder A. Lele R. Tyagi A. Ghosh